Food intake, particularly ingestion of carbohydrate-rich food, increases GLP-1 secretion, which promotes post-prandial insulin secretion, -cell proliferation, and glucose homeostasis, contributing to reducing glucose levels and aiding weight loss
GLP-1 medications have become a popular option for managing type 2 diabetes and supporting weight loss
Short-acting GLP-1RAs, such as lixisenatide, maintain robust effects on gastric emptying, whereas long-acting agents, like liraglutide and semaglutide, exhibit reduced efficacy due to continuous receptor activation
What pricing and reimbursement risks (e.g., VBP, biosimilar entry) could impact revenue forecasts after 2026
Managing Cold Sensitivity While Using Weight Loss Injections If you experience increased cold sensitivity during weight loss treatment, several practical strategies can help you maintain comfort whilst continuing your therapeutic programme
Phase 3 trials are ongoing